Nonetheless, exosomes retrieved from blood of CML patients contain amphiregulin, an inducer of EGFR activation in stromal cells located in the bone marrow that might be used as biomarker[195]. The gene discussed is EGFR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.